Monday, August 30, 2021

COVID-19 antibody study shows downside of not receiving second shot

A new study shows that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 percent in adults with prior cases of COVID-19, and tests how well current vaccines resist emerging variants. The study also showed that prior exposure to SARS-CoV-2 does not guarantee a high level of antibodies, nor does it guarantee a robust antibody response to the first vaccine dose. This directly contradicts the assumption that contracting COVID will naturally make someone immune to re-infection. The findings further support vaccination (and two doses), even for people who have contracted the virus previously.

from Latest Science News -- ScienceDaily https://ift.tt/3kAVYO3

No comments:

Post a Comment

Ebola and hantavirus can start like the flu but turn deadly fast

Two dangerous viruses are back in the spotlight, reminding health officials how quickly infectious diseases can become serious threats. Hant...